MétaCan
Menu
← Back to cohort
Record W4397046409 · doi:10.1681/asn.20223311s1869a

Differential Expression of Renal and Hepatic PCSK9 During Development of Hypercholesterolemia in the Puromycin Aminonucleoside Nephrosis Rat Model of Nephrotic Syndrome

2022· article· en· W4397046409 on OpenAlexaff
Eduardo Molina‐Jijón, Camille Macé, Carmen Ávila-Casado, Lionel C. Clément

Bibliographic record

VenueJournal of the American Society of Nephrology · 2022
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsUniversity Health Network
Fundersnot available
KeywordsNephrosisPuromycinNephrotic syndromeInternal medicineEndocrinologyMedicineBiologyProtein biosynthesisBiochemistry

Abstract

fetched live from OpenAlex

Background: In the US, 85% of patients with nephrotic syndrome (NS) have hypercholesterolemia, compared to 31.5% of the general population. Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a main role in the regulation of LDL-cholesterol in the liver. In the kidney, PCSK9 is expressed in the cortical collecting duct (CCD) where acts as a chaperone for the epithelial sodium channel. We showed that PCSK9 is increased in kidney biopsies of patients with NS and that it is implicated in the initiation of hypercholesterolemia in two animal models, Buffalo-Mna rats (model of focal and segmental glomerulosclerosis) and Rrm2b-/- mice (model of collapsing glomerulopathy) (Molina-Jijon et al, 2020). In this study, we investigate the expression of PCSK9 in puromycin aminonucleoside (PAN) nephrosis in rats, a model of human Minimal Change Disease (MCD) Methods: Sprague-Dawley rats were injected with saline 0.9% (control) or PAN (15 mg/100 g). Rats were euthanized daily from day 1 to 7 after PAN injection. Proteinuria, PCSK9 and serum cholesterol were assessed. PCSK9 gene and protein expression in liver and kidney were studied by RealTime PCR and Western blot Results: Control rats did not develop proteinuria, hypercholesterolemia or high serum PCSK9. PAN rats developed proteinuria (mg/18h) from day 4 after injection (0.82±0.1 day 0; 4.4± 1 day 4; 63±17 day 5; 145±7 day 6 and 128±13 day 7). Serum PCSK9 (ng/mL) significantly increased from day 5 (144±26 day 0; 404±81 day 5; 1635±263 day 6; 1816 ± 191 day 7), and hypercholesterolemia (mg/dL) significantly developed from day 6 to 7 (93±6 day 0; 326.80±37 day 6; 352±10 day 7). In the kidney, PCSK9 expression increased from day 3 after injection, and was not modified in the liver. Similarly, PCSK9 mRNA increased in the kidney from day 5 with no significant modification in the liver (fold change mRNA expression=18.9 for renal cortex vs 2.4 for liver day 5; 11.4 vs 2.6 day 6; 20.5 vs 1.6 day 7) Conclusions: As rats develop NS, PCSK9 protein level increase in the kidney and serum and did not change in the liver. PCSK9 from CCD may play a role in the initiation of hypercholesterolemia in MCD-related nephrotic syndrome and could become a new therapeutic target to prevent development of hypercholesterolemia in nephrotic syndrome patients Funding: NIDDK Support

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.244
Teacher spread0.227 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicLipoproteins and Cardiovascular Health→French-language works237,207→